Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals, Inc. (ALNY) is a Healthcare stock tracked by StreetAlpha. ALNY reports earnings on Thu, Oct 29, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 14 firms (11 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in ALNY, 0% of them bullish and 100% bearish. In the past 30 days there were 3 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 14 | Wells Fargo | Target lowered | Hold | — |
| Oct 8 | RBC Capital | Target lowered | Buy | — |
| Sep 30 | JP Morgan | Target lowered | Buy | — |
| Sep 8 | Jefferies | Target lowered | Hold | — |
| Sep 2 | HC Wainwright & Co. | Reiterated | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ALNY is in one of them and how their past ALNY trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ALNY in an article yet. Here's the latest on the wider market.
ALNY Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Buy | $1K – $15K | Aug 28, 2026 | Sep 22, 2026 | 25 d |
| Donald J TrumpExecutive branch | Buy | $1K – $15K | Aug 10, 2026 | Sep 22, 2026 | 43 d |
| Donald J TrumpExecutive branch | Buy | $1K – $15K | Jul 17, 2026 | Sep 22, 2026 | 67 d |
| Cory BookerD · NJ | Sell | $1K – $15K | Aug 11, 2026 | Sep 9, 2026 | 29 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | May 18, 2026 | Jul 1, 2026 | 44 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.